Association of ITGA2 Dual Site Variants with Recurrent Ischemic Events in Patients Undergoing Stenting for Symptomatic Intracranial Atherosclerotic Stenosis

X Li, Y Dong, J Ye, S Cheng, H Yang, Z Li… - Authorea …, 2023 - essopenarchive.org
Objective: We aimed to investigate the relationship between gene polymorphisms and the
occurrence of adverse clinical events following dual antiplatelet therapy in Patients with …
相关文章

Association of ITGA2 Dual Site Variants with Recurrent Ischemic Events in Patients Undergoing Stenting for Symptomatic Intracranial Atherosclerotic Stenosis

X Li, Y Dong, J Ye, S Cheng, H Yang, Z Li, X Di, X Lou… - authorea.com
Objective: We aimed to investigate the relationship between gene polymorphisms and the
occurrence of adverse clinical events following dual antiplatelet therapy in Patients with …

Association of ITGA2 Dual Site Variants with Recurrent Ischemic Events in Patients Undergoing Stenting for Symptomatic Intracranial Atherosclerotic StenosisAuthor …

Y Dong, J Ye, S Cheng, H Yang, Z Li, X Di, X Lou, X Li… - 2023 - europepmc.org
Objective: We aimed to investigate the relationship between gene polymorphisms and the
occurrence of adverse clinical events following dual antiplatelet therapy in Patients with …

Association of ITGA2 Dual Site Variants with Recurrent Ischemic Events in Patients Undergoing Stenting for Symptomatic Intracranial Atherosclerotic Stenosis

X Li, Y Dong, J Ye, S Cheng, H Yang, Z Li… - Authorea …, 2023 - advance.sagepub.com
Objective: We aimed to investigate the relationship between gene polymorphisms and the
occurrence of adverse clinical events following dual antiplatelet therapy in Patients with …

Association of ITGA2 Dual Site Variants with Recurrent Ischemic Events in Patients Undergoing Stenting for Symptomatic Intracranial Atherosclerotic StenosisAuthor …

Y Dong, J Ye, S Cheng, H Yang, Z Li, X Di, X Lou, X Li… - 2023 - researchsquare.com
Objective We aimed to investigate the relationship between gene polymorphisms and the
occurrence of adverse clinical events following dual antiplatelet therapy in Patients with …

Association of ITGA2 Dual Site Variants with Recurrent Ischemic Events in Patients Undergoing Stenting for Symptomatic Intracranial Atherosclerotic Stenosis

X Li, Y Dong, J Ye, S Cheng, H Yang, Z Li, X Di… - Authorea …, 2023 - techrxiv.org
Objective: We aimed to investigate the relationship between gene polymorphisms and the
occurrence of adverse clinical events following dual antiplatelet therapy in Patients with …

Association of ITGA2 Dual Site Variants with Recurrent Ischemic Events in Patients Undergoing Stenting for Symptomatic Intracranial Atherosclerotic Stenosis

X Li, Y Dong, J Ye, S Cheng, H Yang, Z Li, X Di, X Lou… - 2023 - advance.sagepub.com
Objective: We aimed to investigate the relationship between gene polymorphisms and the
occurrence of adverse clinical events following dual antiplatelet therapy in Patients with …

Association of ITGA2 Dual Site Variants with Recurrent Ischemic Events in Patients Undergoing Stenting for Symptomatic Intracranial Atherosclerotic Stenosis

X Li, Y Dong, J Ye, S Cheng, H Yang, Z Li, X Di, X Lou… - 2023 - europepmc.org
Objective: We aimed to investigate the relationship between gene polymorphisms and the
occurrence of adverse clinical events following dual antiplatelet therapy in Patients with …